MARCUS SCHABACKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2021-04-13 Marcus Schabacker
2022-05-31 Name Fees earned or paid in cash ($) Equity awards ($) Total ($) Marcus Schabacker 37,000 76,594 113,594 Consists of RSA’s equivalent to 15,957 shares of Common Stock, valued at $4.80 per share (the closing price per share on the date of the award). As of December 31, 2021, Marcus Schabacker had outstanding 15,957 RSA’s.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22